ArticleTrials2018

Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.

Julia Geissler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.